These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16934691

  • 1. Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.
    Miao Y, Fisher DR, Quinn TP.
    Nucl Med Biol; 2006 Aug; 33(6):723-33. PubMed ID: 16934691
    [Abstract] [Full Text] [Related]

  • 2. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
    Miao Y, Hoffman TJ, Quinn TP.
    Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
    Miao Y, Owen NK, Fisher DR, Hoffman TJ, Quinn TP.
    J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of a 177Lu-labeled DOTA conjugated alpha-melanocyte-stimulating hormone peptide in a murine melanoma-bearing mouse model.
    Miao Y, Shelton T, Quinn TP.
    Cancer Biother Radiopharm; 2007 Jun; 22(3):333-41. PubMed ID: 17651039
    [Abstract] [Full Text] [Related]

  • 7. In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy.
    Miao Y, Owen NK, Whitener D, Gallazzi F, Hoffman TJ, Quinn TP.
    Int J Cancer; 2002 Oct 10; 101(5):480-7. PubMed ID: 12216078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
    Yang J, Hu CA, Miao Y.
    Amino Acids; 2015 Apr 10; 47(4):813-23. PubMed ID: 25557051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
    Miao Y, Benwell K, Quinn TP.
    J Nucl Med; 2007 Jan 10; 48(1):73-80. PubMed ID: 17204701
    [Abstract] [Full Text] [Related]

  • 13. Effect of Ibuprofen as an Albumin Binder on Melanoma-Targeting Properties of 177Lu-Labeled Ibuprofen-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides.
    Qiao Z, Xu J, Gallazzi F, Fisher DR, Gonzalez R, Kwak J, Miao Y.
    Mol Pharm; 2024 Aug 05; 21(8):4004-4011. PubMed ID: 38973113
    [Abstract] [Full Text] [Related]

  • 14. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP.
    Cancer Res; 2000 Oct 15; 60(20):5649-58. PubMed ID: 11059756
    [Abstract] [Full Text] [Related]

  • 15. Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.
    Guo H, Yang J, Gallazzi F, Prossnitz ER, Sklar LA, Miao Y.
    Bioconjug Chem; 2009 Nov 15; 20(11):2162-8. PubMed ID: 19817405
    [Abstract] [Full Text] [Related]

  • 16. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
    Eberle AN, Froidevaux S.
    J Mol Recognit; 2003 Nov 15; 16(5):248-54. PubMed ID: 14523936
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.
    Miao Y, Gallazzi F, Guo H, Quinn TP.
    Bioconjug Chem; 2008 Feb 15; 19(2):539-47. PubMed ID: 18197608
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.
    Yang J, Lu J, Miao Y.
    Mol Pharm; 2012 May 07; 9(5):1418-24. PubMed ID: 22452443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.